ClinicalTrials.Veeva

Menu

Metabolomics Fingerprinting and Metabolic Dynamics After HIV Infection

S

Sichuan Academy of Medical Sciences

Status

Unknown

Conditions

HIV

Study type

Observational

Funder types

Other

Identifiers

NCT01828268
META-HA-001-2013

Details and patient eligibility

About

The purpose of this plot study is to find out the relationship between metabolic changes and anti-retroviral therapy (ART), life style and clinical conditions of HIV-infected patients using nuclear magnetic resonance (NMR) based systems biology approach and metabolomics methodology.

Full description

Since the clinical application of anti-retroviral therapy (ART) in 1997, the life expectancy of HIV infected patients has been prolonged greatly. However,side effects of ART including metabolic abnormalities have become the main factors influencing patients' quality of life. Among which the abnormal lipid metabolism plays an important role. Meanwhile, metabolic conditions differ from patients applying to different combinations of ART drugs,life style and clinical conditions.

Metabolomics can measure the dynamic metabolic responses of the body to stimuli or modifications. Using nuclear magnetic resonance (NMR) as tools can systematically analyse the process of lipid metabolism. Metabolomics fingerprinting can be defined as the complete complement of small molecule (< 1500 Da) metabolites found in a specific cell, body fluid, organ or organism.

Therefore, the study of the impact of metabolic changes and anti-retroviral therapy (ART), life style and clinical conditions is of importance in enhancing the adherence and improving the clinical outcomes of HIV infected patients.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of HIV infection

Exclusion criteria

  • Pregnancy
  • Individual who is participating in other trial(s)

Trial design

100 participants in 1 patient group

HIV infectors
Description:
100 confirmed HIV-1 infected patients who meet inclusion criteria.

Trial contacts and locations

1

Loading...

Central trial contact

Hua JIANG, PhD; Bing CAI, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems